1. Home
  2. MREO vs SB Comparison

MREO vs SB Comparison

Compare MREO & SB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • SB
  • Stock Information
  • Founded
  • MREO 2015
  • SB 2007
  • Country
  • MREO United Kingdom
  • SB Monaco
  • Employees
  • MREO N/A
  • SB N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • SB Marine Transportation
  • Sector
  • MREO Health Care
  • SB Consumer Discretionary
  • Exchange
  • MREO Nasdaq
  • SB Nasdaq
  • Market Cap
  • MREO 438.8M
  • SB 395.3M
  • IPO Year
  • MREO N/A
  • SB 2008
  • Fundamental
  • Price
  • MREO $2.87
  • SB $3.73
  • Analyst Decision
  • MREO Strong Buy
  • SB Strong Buy
  • Analyst Count
  • MREO 5
  • SB 1
  • Target Price
  • MREO $7.60
  • SB $5.00
  • AVG Volume (30 Days)
  • MREO 1.3M
  • SB 376.4K
  • Earning Date
  • MREO 08-12-2025
  • SB 07-28-2025
  • Dividend Yield
  • MREO N/A
  • SB 5.38%
  • EPS Growth
  • MREO N/A
  • SB N/A
  • EPS
  • MREO N/A
  • SB 0.67
  • Revenue
  • MREO N/A
  • SB $290,312,000.00
  • Revenue This Year
  • MREO N/A
  • SB N/A
  • Revenue Next Year
  • MREO $52.34
  • SB $13.41
  • P/E Ratio
  • MREO N/A
  • SB $5.42
  • Revenue Growth
  • MREO N/A
  • SB N/A
  • 52 Week Low
  • MREO $1.58
  • SB $3.02
  • 52 Week High
  • MREO $5.02
  • SB $6.22
  • Technical
  • Relative Strength Index (RSI)
  • MREO 61.43
  • SB 51.14
  • Support Level
  • MREO $2.63
  • SB $3.56
  • Resistance Level
  • MREO $2.85
  • SB $3.91
  • Average True Range (ATR)
  • MREO 0.16
  • SB 0.09
  • MACD
  • MREO -0.01
  • SB -0.02
  • Stochastic Oscillator
  • MREO 79.41
  • SB 48.57

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About SB Safe Bulkers Inc ($0.001 par value)

Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services.

Share on Social Networks: